FAKTOR-OPTIONSSCHEIN - POLE GROU | Market Closed - Börse Stuttgart 05:16:22 2024-07-11 am EDT | ||
| 1.64 EUR | -1.20% |
|
| Current month | +11.41% | ||
| 1 month | -13.09% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
POLYPEPTIDE GROUP AG
Latest news about POLYPEPTIDE GROUP AG
More news
| Date | Price | Change |
|---|---|---|
| 24-07-11 | 1.64 | -1.20% |
| 24-07-10 | 1.66 | +5.73% |
| 24-07-09 | 1.57 | -7.10% |
| 24-07-08 | 1.69 | +1.20% |
| 24-07-05 | 1.67 | +5.03% |
Delayed Quote Börse Stuttgart
Last update July 11, 2024 at 05:16 am EDT
More quotesStatic data
| Product type | Warrant Esotici e Strutturati |
|---|---|
| Buy / Sell | CALL |
| Underlying | POLYPEPTIDE GROUP AG |
| Issuer | Morgan Stanley |
| WKN | MD69AB |
| ISIN | DE000MD69AB7 |
| Date issued | 2022-07-14 |
| Strike | 15.03 CHF |
| Maturity | Unlimited |
| Parity | 9.78 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.89 € |
|---|---|
| Lowest since issue | 0.41 € |
| Spread | 0.04 € |
| Spread % | 2.38% |
Company Profile
Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.
Sector
-
Consensus: PolyPeptide Group AG
Sell
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
30.87
EUR
Average target price
26.74
EUR
Spread / Average Target
-13.39%
- Stock Market
- Certificates
- Certificat
